Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-20-000002

CEO acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
BUNKA CHRISTOPHER CEO 2020-05-06 Grant or award +200,000 $0.23 $46,000 6,281,844 I
Loading xslF345X03/primary_doc.xml…